First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer

Clinical trial NCT01669226 · COMPLETED

Trial details

NCT number: NCT01669226
Sponsor: Shanghai Gynecologic Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bulky Stage IIIC and IV Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2009-04-01
Primary completion: 2015-09-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.